AMIX — Autonomix Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $5.59m
- -$3.55m
Annual cashflow statement for Autonomix Medical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -13.3 | -1.99 | -15.4 | -11.4 |
| Depreciation | ||||
| Non-Cash Items | 12.7 | — | 8.62 | 1.73 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 0.204 | 0.136 | 0.079 | 1.24 |
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Cash from Operating Activities | -0.387 | -1.85 | -6.65 | -8.26 |
| Capital Expenditures | — | — | -0.019 | -0.014 |
| Purchase of Fixed Assets | ||||
| Cash from Investing Activities | — | — | -0.019 | -0.014 |
| Financing Cash Flow Items | 0.29 | — | -1.3 | -1.23 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 2.43 | 0.675 | 14.4 | 8.8 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 2.04 | -1.18 | 7.74 | 0.528 |